| Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies S Xu, I Ilyas, PJ Little, H Li, D Kamato, X Zheng, S Luo, Z Li, P Liu, J Han, ... Pharmacological reviews 73 (3), 924-967, 2021 | 545 | 2021 |
| Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies S Xu, I Ilyas, J Weng Acta Pharmacologica Sinica 44 (4), 695-709, 2023 | 204 | 2023 |
| GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential X Ma, Z Liu, I Ilyas, PJ Little, D Kamato, A Sahebka, Z Chen, S Luo, ... International journal of biological sciences 17 (8), 2050, 2021 | 120 | 2021 |
| Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics Z Liu, X Ma, I Ilyas, X Zheng, S Luo, PJ Little, D Kamato, A Sahebkar, ... Theranostics 11 (9), 4502, 2021 | 89 | 2021 |
| The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction S Xu, Y Liu, Y Ding, S Luo, X Zheng, X Wu, Z Liu, I Ilyas, S Chen, S Han, ... Signal Transduction and Targeted Therapy 6 (1), 266, 2021 | 38 | 2021 |
| Mouse models of atherosclerosis in translational research I Ilyas, PJ Little, Z Liu, Y Xu, D Kamato, BC Berk, J Weng, S Xu Trends in Pharmacological Sciences 43 (11), 920-939, 2022 | 37 | 2022 |
| A review on therapeutical potential of paeonol in atherosclerosis W Yu, I Ilyas, N Aktar, S Xu Frontiers in Pharmacology 13, 950337, 2022 | 15 | 2022 |
| Ratiometric pH sensing and imaging in living cells with dual-emission semiconductor polymer dots P Chen, I Ilyas, S He, Y Xing, Z Jin, C Huang Molecules 24 (16), 2923, 2019 | 11 | 2019 |
| Therapeutic potential of paeoniflorin in atherosclerosis: a cellular action and mechanism-based perspective W Yu, I Ilyas, X Hu, S Xu, H Yu Frontiers in Immunology 13, 1072007, 2022 | 8 | 2022 |
| Vascular homeostasis in atherosclerosis: A holistic overview S Xu, QR Lyu, I Ilyas, XY Tian, J Weng Frontiers in Immunology 13, 976722, 2022 | 8 | 2022 |
| Non-mouse models of atherosclerosis: approaches to exploring the translational potential of new therapies D Kamato, I Ilyas, S Xu, PJ Little International Journal of Molecular Sciences 23 (21), 12964, 2022 | 5 | 2022 |
| A proteome-wide screen identifies the calcium binding proteins, S100A8/S100A9, as clinically relevant therapeutic targets in aortic dissection H Jiang, Y Zhao, M Su, L Sun, M Chen, Z Zhang, I Ilyas, Z Wang, PJ Little, ... Pharmacological Research 199, 107029, 2024 | 2 | 2024 |
| Bioactive Flavonoids in Protecting Against Endothelial Dysfunction and Atherosclerosis Y Yin, J Xu, I Ilyas, S Xu | | 2024 |
| The natural polyphenol fisetin in atherosclerosis prevention: a mechanistic review W Yu, Y Zhao, I Ilyas, L Wang, PJ Little, S Xu Journal of Pharmacy and Pharmacology, rgae053, 2024 | | 2024 |
